Deep Dive: CGRP Therapies: First-Line Status, New Safety Signal
A practicing clinician’s guide to all 8 FDA-approved CGRP-targeted agents: mechanism, agent selection, safety, and monitoring For most…
FDA Seeks Schedule I Status for ‘Legal Morphine’
The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance derived from kratom leaves, be classified as…